why choose us

First received: February 11, 2023

Clinical Trial: HCC Staging Modified by Tumor Micronecrosis

Study Status: Completed

Recruit Status: Completed

Condition: Hepatocellular Carcinoma

Study Type: Observational


Official Title: Optimizing Hepatocellular Carcinoma Disease Staging Systems by Incorporating Tumor Micronecrosis: A Multi-institutional Retrospective Study

Brief Summary: Tumor micronecrosis is a pathological feature that reflects malignant biological behavior in hepatocellular carcinoma (HCC). This study aimed to evaluate the prognostic significance of tumor micronecrosis based on the current BCLC and TNM staging systems, and futher improve the performance of the staging models by establishing modified new staging models including tumor micronecrosis.

Read more